Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...

In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India's first AI-led ...

The study authors say their findings argue for careful reading of CT scans done for other reasons that may reveal the ...

Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients ...

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026LONDON and PHOENIX, Ariz., March 18, 2025 ...

It invested in a robotic, noninvasive technology for biopsies of hard-to-reach lesions in the lungs and to remove suspected ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

Good Samaritan announced the acquisition of a new state-of-the-art robotic-assisted platform for minimally invasive lung ...

Colonoscopies, mammograms, Pap smears and prostate exams are designed to detect early signs of cancer. Local health care ...

Researchers at the International Agency for Research on Cancer (IARC ... even before discrete lung nodules develop," he added. "However, lung CT scans remain the best diagnostic tool for those ...